Matches in Nanopublications for { ?s ?p "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP885548.RAlachvTbtFLsCgIq-du_V1cLBh-X5rOUZEHI8v8f9mVo130_assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885548.RAlachvTbtFLsCgIq-du_V1cLBh-X5rOUZEHI8v8f9mVo130_provenance.
- assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1021069.RAa6hZJDl5OT59PlCiobPRTM9HM2-J-XeKHlQv50OuJjw130_assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021069.RAa6hZJDl5OT59PlCiobPRTM9HM2-J-XeKHlQv50OuJjw130_provenance.
- NP644473.RAnfHQMhqawB674Y4ljquood5AtsvgeC77QWE0_X6T3Fg130_assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644473.RAnfHQMhqawB674Y4ljquood5AtsvgeC77QWE0_X6T3Fg130_provenance.
- NP849371.RAlrJ9CMpPE68pS0i8klRZGyZm0NUYmComhRffV_SWdag130_assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849371.RAlrJ9CMpPE68pS0i8klRZGyZm0NUYmComhRffV_SWdag130_provenance.
- NP598212.RAxHif-veUVtTT7D4lS3uMb22L578DbD5o-FG3zVVEgRA130_assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598212.RAxHif-veUVtTT7D4lS3uMb22L578DbD5o-FG3zVVEgRA130_provenance.
- NP1021064.RAKEMk0F7MUlvdXkROAidHnJyY3EYhJpx9cUsNLK5he9I130_assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021064.RAKEMk0F7MUlvdXkROAidHnJyY3EYhJpx9cUsNLK5he9I130_provenance.
- NP1021066.RAH1ai5NaSh8BIVXG6e56zT9PjuOkhSiyijNDsKPtBono130_assertion description "[Treatment of fetal tibiae explants with mitogen activated protein kinase 1 and 2 inhibitors U0126 and PD325901 rescues the Npr2(pwe/pwe) growth defect, providing a promising foundation for skeletal dysplasia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021066.RAH1ai5NaSh8BIVXG6e56zT9PjuOkhSiyijNDsKPtBono130_provenance.